Expand GOSS Menu
GOSS MENU

GOSS Latest Press Releases

-- March 25, 2026 --

GOSS: Announces Topline Results for Phase 3 PROSERA Trial -- LEVI & KORSINSKY, LLP PRNewswire 9:01 AM

-- March 24, 2026 --

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Gossamer Bio, Inc. - GOSS Globe Newswire 5:33 PM

-- March 19, 2026 --

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Gossamer Bio, Inc. - GOSS PRNewswire 10:10 AM
GOSS: Management Optimistic About Topline Results -- LEVI & KORSINSKY, LLP Investigates After Trial Fails Globe Newswire 9:00 AM

-- March 18, 2026 --

GOSS: Management Optimistic About Topline Results -- LEVI & KORSINSKY, LLP Investigates After Trial Fails PRNewswire 9:00 AM
Gossamer Bio, Inc. Investigated by the Portnoy Law Firm Globe Newswire 9:00 AM

-- March 17, 2026 --

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Gossamer Bio, Inc. - GOSS Globe Newswire 6:10 PM
Gossamer Bio Announces Fourth Quarter and Full-Year 2025 Financial Results and Provides Corporate Update Business Wire 4:01 PM

-- March 5, 2026 --

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Gossamer Bio, Inc. - GOSS PRNewswire 5:07 PM
GOSS: Management Optimistic About Topline Results -- LEVI & KORSINSKY, LLP Investigates After Trial Fails Globe Newswire 9:00 AM

-- March 4, 2026 --

GOSS: Announces Topline Results for Phase 3 PROSERA Trial -- LEVI & KORSINSKY, LLP PRNewswire 6:50 PM

-- March 3, 2026 --

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Gossamer Bio, Inc. - GOSS Globe Newswire 4:08 PM

-- March 1, 2026 --

GOSS Investors Have Opportunity to Join Gossamer Bio, Inc. Fraud Investigation with the Schall Law Firm Business Wire 4:07 PM

-- February 26, 2026 --

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Gossamer Bio, Inc. - GOSS PRNewswire 3:18 PM

-- February 23, 2026 --

BREAKING: Gossamer Bio Investors Should Contact Block & Leviton to Potentially Recover Losses After Shares Fall Over 75% Globe Newswire 12:40 PM
Gossamer Bio Shareholders Are Encouraged to Contact Johnson Fistel for More Information About Potentially Recovering Their Losses Globe Newswire 11:26 AM
Gossamer Bio Announces Topline Results from the Phase 3 PROSERA Study Evaluating Seralutinib in Pulmonary Arterial Hypertension Business Wire 8:00 AM

-- January 8, 2026 --

Gossamer Bio Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) Business Wire 5:30 PM

-- December 9, 2025 --

Gossamer Bio Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) Business Wire 5:30 PM

-- November 24, 2025 --

Gossamer Bio to Participate in Upcoming Investor Conferences Business Wire 4:01 PM

-- November 7, 2025 --

Gossamer Bio Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) Business Wire 5:30 PM
Gossamer Bio to Participate in Upcoming Investor Conferences Business Wire 7:31 AM

-- November 5, 2025 --

Gossamer Bio Announces Third Quarter 2025 Financial Results and Provides Business Update Business Wire 4:01 PM
Market Data Delayed 15 Minutes